Formation Bio announced a $600 million fund structured to expand pipeline execution without issuing parent equity, using a hub-and-spoke approach. The financing model is designed to reach institutions that typically invest through funds and to support broader development at lower friction than traditional single-company financing. For small and mid-sized biotech development, the structure signals continued demand for outsourced manufacturing and development capacity paired with capital vehicles that can accelerate program breadth. The announcement also reinforces that buildout of platform infrastructure—teams, CDMOs, and partner networks—remains a core strategy for companies trying to expand indications and modalities simultaneously.